Livagen is a synthetic tetrapeptide bioregulator investigated for its interactions with chromatin structure and gene expression pathways in preclinical models of hepatic and immune cell regulation.
Molecular Composition and Mechanistic Profile
Peptide identity: Livagen is a four amino acid peptide with the sequence Lys Glu Asp Ala (KEDA).
Origin: Synthetic short regulatory peptide developed from sequences associated with liver tissue polypeptides in the bioregulator class.
Mechanistically, Livagen has been associated with:
Induction of chromatin decondensation and activation of ribosomal genes in lymphocyte preparations from experimental systems.
Modulation of epigenetic architecture that may restore accessibility of condensed genetic regions in aged cell models.
Influence on digestive enzyme activity and related metabolic processes in gastrointestinal and hepatic tissue studies.
These properties position Livagen as a tool for studying tissue specific bioregulatory signaling in hepatic models.
Integrated Research Applications
Livagen is examined in systems focused on liver and chromatin regulation. Representative domains include:
Hepatic cell models: Investigation of gene expression and metabolic enzyme markers in cultured hepatocytes and animal tissue preparations.
Chromatin remodeling studies: Evaluation of deheterochromatinization and transcriptional reactivation in experimental lymphocyte systems.
Immune and aging related research: Assessment of effects on cellular senescence markers and immune cell function in laboratory models.
Comparative bioregulator research: Use alongside related short peptides to explore organ specific regulatory mechanisms in controlled laboratory settings.
Overall, Livagen serves as a research tool for exploring short peptide modulation of hepatic tissue homeostasis and epigenetic networks.
Analytical Validation, Formulation, and Storage
NextGenPeps supplies Livagen as a high purity research peptide. Typical quality and handling features include:
Purity: ≥99% verified by HPLC.
Formulation: White lyophilized powder in sealed glass vials, intended for reconstitution with appropriate research grade solvent for experimental use only. No dosing guidance is provided for any organism.
Storage: Keep lyophilized material in a cool dark dry environment; long term storage at or below −20 °C. Store reconstituted solutions refrigerated, minimize freeze thaw cycles, and use within laboratory defined stability windows.
NextGenPeps supplies Livagen as a high purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
